A COVID-19 vaccine in Russia produced neutralising antibodies in dozens of test subjects, according to a study published in the medical journal The Lancet.
A COVID-19 vaccine in Russia produced neutralising antibodies in dozens of test subjects, according to a study published in the medical journal The Lancet.
Some promising news coming from the Moderna vaccine trial. Researchers say it appears to create a strong immune response in older..
A serious adverse reaction in a volunteer has triggered the safety protocol for the large-scale trial.